Cargando…
Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis
Cognitive reserve (CR) may reduce the risk of dementia. We summarized the effect of CR on progression to mild cognitive impairment (MCI) or dementia in studies accounting for Alzheimer’s disease (AD)-related structural pathology and biomarkers. Literature search was conducted in Web of Science, PubM...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790730/ https://www.ncbi.nlm.nih.gov/pubmed/33415533 http://dx.doi.org/10.1007/s11065-021-09478-4 |
_version_ | 1783633482144022528 |
---|---|
author | Nelson, Monica E. Jester, Dylan J. Petkus, Andrew J. Andel, Ross |
author_facet | Nelson, Monica E. Jester, Dylan J. Petkus, Andrew J. Andel, Ross |
author_sort | Nelson, Monica E. |
collection | PubMed |
description | Cognitive reserve (CR) may reduce the risk of dementia. We summarized the effect of CR on progression to mild cognitive impairment (MCI) or dementia in studies accounting for Alzheimer’s disease (AD)-related structural pathology and biomarkers. Literature search was conducted in Web of Science, PubMed, Embase, and PsycINFO. Relevant articles were longitudinal, in English, and investigating MCI or dementia incidence. Meta-analysis was conducted on nine articles, four measuring CR as cognitive residual of neuropathology and five as composite psychosocial proxies (e.g., education). High CR was related to a 47% reduced relative risk of MCI or dementia (pooled-hazard ratio: 0.53 [0.35, 0.81]), with residual-based CR reducing risk by 62% and proxy-based CR by 48%. CR protects against MCI and dementia progression above and beyond the effect of AD-related structural pathology and biomarkers. The finding that proxy-based measures of CR rivaled residual-based measures in terms of effect on dementia incidence underscores the importance of early- and mid-life factors in preventing dementia later. |
format | Online Article Text |
id | pubmed-7790730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-77907302021-01-08 Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis Nelson, Monica E. Jester, Dylan J. Petkus, Andrew J. Andel, Ross Neuropsychol Rev Review Cognitive reserve (CR) may reduce the risk of dementia. We summarized the effect of CR on progression to mild cognitive impairment (MCI) or dementia in studies accounting for Alzheimer’s disease (AD)-related structural pathology and biomarkers. Literature search was conducted in Web of Science, PubMed, Embase, and PsycINFO. Relevant articles were longitudinal, in English, and investigating MCI or dementia incidence. Meta-analysis was conducted on nine articles, four measuring CR as cognitive residual of neuropathology and five as composite psychosocial proxies (e.g., education). High CR was related to a 47% reduced relative risk of MCI or dementia (pooled-hazard ratio: 0.53 [0.35, 0.81]), with residual-based CR reducing risk by 62% and proxy-based CR by 48%. CR protects against MCI and dementia progression above and beyond the effect of AD-related structural pathology and biomarkers. The finding that proxy-based measures of CR rivaled residual-based measures in terms of effect on dementia incidence underscores the importance of early- and mid-life factors in preventing dementia later. Springer US 2021-01-08 2021 /pmc/articles/PMC7790730/ /pubmed/33415533 http://dx.doi.org/10.1007/s11065-021-09478-4 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Nelson, Monica E. Jester, Dylan J. Petkus, Andrew J. Andel, Ross Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis |
title | Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis |
title_full | Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis |
title_fullStr | Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis |
title_short | Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis |
title_sort | cognitive reserve, alzheimer’s neuropathology, and risk of dementia: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790730/ https://www.ncbi.nlm.nih.gov/pubmed/33415533 http://dx.doi.org/10.1007/s11065-021-09478-4 |
work_keys_str_mv | AT nelsonmonicae cognitivereservealzheimersneuropathologyandriskofdementiaasystematicreviewandmetaanalysis AT jesterdylanj cognitivereservealzheimersneuropathologyandriskofdementiaasystematicreviewandmetaanalysis AT petkusandrewj cognitivereservealzheimersneuropathologyandriskofdementiaasystematicreviewandmetaanalysis AT andelross cognitivereservealzheimersneuropathologyandriskofdementiaasystematicreviewandmetaanalysis |